An Evaluation of the Efficacy of Preclinical Models of Lung Cancer Drugs
E. Pan, D. Bogumil, V. Cortessis, S. Yu, J. Nieva
This study evaluates preclinical models of lung cancer drugs and finds no significant linear trend between preclinical success and drug approval.
bioRxiv · Jan 29, 2020Cancer Biology